Evidence map›Paper›PMID 30459830›Full record

ArticleEvolutionary applications2018

Mosaics, mixtures, rotations or pyramiding: What is the optimal strategy to deploy major gene resistance?

Loup Rimbaud, Julien Papaïx, Luke G Barrett, Jeremy J Burdon, Peter H Thrall

Abstract read
In one paragraph

Article in Evolutionary applications, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed.

  1. Adaptation ofEvolutionary applications · 2025
    Article
  2. Article
  3. Review
  4. Article
  5. Review
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Review
  12. The socio-economic challenges of managing pathogen evolution in agriculture.Philosophical transactions of the Royal Society of London. Series B, Biological sciences · 2023
    Review
  13. Article
  14. Review
  15. Article
  16. Article
  17. Review
  18. Article
  19. Genetic diversity and disease: The past, present, and future of an old idea.Evolution; international journal of organic evolution · 2022
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Loup RimbaudCSIRO Agriculture and Food Canberra Australian Capital Territory Australia.ORCID 0000-0002-8098-9984
Julien PapaïxBioSP, INRA Avignon France.
Luke G BarrettCSIRO Agriculture and Food Canberra Australian Capital Territory Australia.
Jeremy J BurdonCSIRO Agriculture and Food Canberra Australian Capital Territory Australia.
Peter H ThrallCSIRO Agriculture and Food Canberra Australian Capital Territory Australia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Once deployed uniformly in the field, genetically controlled plant resistance is often quickly overcome by pathogens, resulting in dramatic losses. Several strategies have been proposed to constrain the evolutionary potential of pathogens and thus increase resistance durability. These strategies can be classified into four categories, depending on whether resistance sources are varied across time (rotations) or combined in space in the same cultivar (pyramiding), in different cultivars within a field (cultivar mixtures) or among fields (mosaics). Despite their potential to differentially affect both pathogen epidemiology and evolution, to date the four categories of deployment strategies have never been directly compared together within a single theoretical or experimental framework, with regard to efficiency (ability to reduce disease impact) and durability (ability to limit pathogen evolution and delay resistance breakdown). Here, we used a spatially explicit stochastic demogenetic model, implemented in the R package

Indexed as

demogenetic modeldeployment strategydurable resistanceevolutionary epidemiologygene‐for‐gene resistancemajor gene resistancePucciniaspatially explicit modelling

Identifiers

PMID30459830
PMCPMC6231482

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.